Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 65
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Increasing the bioavailability of carbohydrates through the interface of mycology and fermentation

    Due to increasing reliance on grain as a source of carbohydrates, shortages can occur if supply is interrupted...

    3D printing a steak with lab-grown cow cells

    We want to make the perfect steak, without slaughtering cows.

    Can we produce plant protein fibers to emulate whole cut cultured meat?

    Meeting the meat demands of a growing population is increasingly difficult and is harmful to the environment...

    Backer Badge Funded